The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by a common condition.

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

A popular drug for treating obesity and diabetes is now showing benefits in fighting a deadly liver disease. Semaglutide, marketed under names including Ozempic and Wegovy, aids weight loss and ...

A latest study has shown promising results in people suffering from metabolic dysfunction-associated steatohepatitis (MASH), ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...